Generation of Mutagens During Arachidonic Acid Metabolism

Overview

Journal Cancer Metastasis Rev

Specialty Oncology

Date 1994 Dec 1

PMID 7712592

Citations 10

Authors

L J Marnett

Affiliations

Soon will be listed here.

Citing Articles

Dual COX-2/TNF-α Inhibitors as Promising Anti-inflammatory and Cancer Chemopreventive Agents: A Review.

Tajdari M, Peyrovinasab A, Bayanati M, Ismail Mahboubi Rabbani M, Abdolghaffari A, Zarghi A Iran J Pharm Res. 2025; 23(1):e151312.

PMID: 39830670 PMC: 11742592. DOI: 10.5812/ijpr-151312.

Interplay of Oxidative Stress, Inflammation, and Autophagy in RAW 264.7 Murine Macrophage Cell Line Challenged with Si/SiO Quantum Dots.

Stanca L, Geicu O, Serban A, Dinischiotu A Materials (Basel). 2023; 16(14).

PMID: 37512357 PMC: 10385521. DOI: 10.3390/ma16145083.

The Role of Nitric Oxide in Cancer: Master Regulator or NOt?.

Khan F, Dervan E, Bhattacharyya D, McAuliffe J, Miranda K, Glynn S Int J Mol Sci. 2020; 21(24).

PMID: 33321789 PMC: 7763974. DOI: 10.3390/ijms21249393.

Evaluation of Ischemia-Modified Albumin, Malondialdehyde, and Advanced Oxidative Protein Products as Markers of Vascular Injury in Diabetic Nephropathy.

Ahmad A, Manjrekar P, Yadav C, Agarwal A, Srikantiah R, Hegde A Biomark Insights. 2016; 11:63-8.

PMID: 27158221 PMC: 4854310. DOI: 10.4137/BMI.S39053.

Modulation of growth and angiogenic potential of oral squamous carcinoma cells in vitro using salvianolic acid B.

Yang Y, Ge P, Jiang L, Li F, Zhu Q BMC Complement Altern Med. 2011; 11:54.

PMID: 21726465 PMC: 3158556. DOI: 10.1186/1472-6882-11-54.

References

Basu A, Marnett L . Unequivocal demonstration that malondialdehyde is a mutagen. Carcinogenesis. 1983; 4(3):331-3. DOI: 10.1093/carcin/4.3.331. View

Frederico L, Kunkel T, Shaw B . A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy. Biochemistry. 1990; 29(10):2532-7. DOI: 10.1021/bi00462a015. View

Robertson I, Sivarajah K, Eling T, Zeiger E . Activation of some aromatic amines to mutagenic products by prostaglandin endoperoxide synthetase. Cancer Res. 1983; 43(2):476-80. View

Sarkar F, Radcliff G, Callewaert D . Purified prostaglandin synthase activates aromatic amines to derivatives that are mutagenic to Salmonella typhimurium. Mutat Res. 1992; 282(4):273-81. DOI: 10.1016/0165-7992(92)90134-4. View

Diczfalusy U, Falardeau P, Hammarstrom S . Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase. FEBS Lett. 1977; 84(2):271-4. DOI: 10.1016/0014-5793(77)80704-7. View

. NTP Toxicology and Carcinogenesis Studies of Malonaldehyde, Sodium Salt (3-Hydroxy-2-propenal, Sodium Salt) (CAS No. 24382-04-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 1988; 331:1-182. View

Stone K, Uzieblo A, Marnett L . Studies of the reaction of malondialdehyde with cytosine nucleosides. Chem Res Toxicol. 1990; 3(5):467-72. DOI: 10.1021/tx00017a013. View

Dix T, Fontana R, Panthani A, Marnett L . Hematin-catalyzed epoxidation of 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by polyunsaturated fatty acid hydroperoxides. J Biol Chem. 1985; 260(9):5358-65. View

Zenser T, Palmier M, Mattammal M, Bolla R, Davis B . Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens. J Pharmacol Exp Ther. 1983; 227(1):139-43. View

10.

Degen G . Prostaglandin-H synthase containing cell lines as tools for studying metabolism and toxicity of xenobiotics. Toxicology. 1993; 82(1-3):243-56. DOI: 10.1016/0300-483x(93)90067-3. View

11.

Sarkar F, Radcliff G, Callewaert D, Marnett L, Eling T, Daston D . Mutagenic response of mouse lymphoma cells after activation of benzidine and 2-aminofluorene with purified prostaglandin H synthase. Mutat Res. 1990; 242(4):319-28. DOI: 10.1016/0165-1218(90)90050-c. View

12.

Yau T . Mutagenicity and cytotoxicity of malonaldehyde in mammalian cells. Mech Ageing Dev. 1979; 11(2):137-44. DOI: 10.1016/0047-6374(79)90031-9. View

13.

Murasaki G, Zenser T, Davis B, Cohen S . Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis. Carcinogenesis. 1984; 5(1):53-5. DOI: 10.1093/carcin/5.1.53. View

14.

Macdonald T, Gutheim W, Martin R, Guengerich F . Oxidation of substituted N,N-dimethylanilines by cytochrome P-450: estimation of the effective oxidation-reduction potential of cytochrome P-450. Biochemistry. 1989; 28(5):2071-7. DOI: 10.1021/bi00431a016. View

15.

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

16.

Strauss B . The 'A rule' of mutagen specificity: a consequence of DNA polymerase bypass of non-instructional lesions?. Bioessays. 1991; 13(2):79-84. DOI: 10.1002/bies.950130206. View

17.

Picot D, Loll P, Garavito R . The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 1994; 367(6460):243-9. DOI: 10.1038/367243a0. View

18.

Eling T, Thompson D, Foureman G, CURTIS J, Hughes M . Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol Toxicol. 1990; 30:1-45. DOI: 10.1146/annurev.pa.30.040190.000245. View

19.

Ji C, Marnett L . Oxygen radical-dependent epoxidation of (7S,8S)-dihydroxy-7,8-dihydrobenzo[a]pyrene in mouse skin in vivo. Stimulation by phorbol esters and inhibition by antiinflammatory steroids. J Biol Chem. 1992; 267(25):17842-8. View

20.

Marnett L . Polycyclic aromatic hydrocarbon oxidation during prostaglandin biosynthesis. Life Sci. 1981; 29(6):531-46. DOI: 10.1016/0024-3205(81)90431-8. View